Increased Ad Spend “Critical” To Successful Rx-To-OTC Switch
This article was originally published in The Tan Sheet
Executive Summary
Sustaining advertising spend on an Rx-to-OTC product at or above the level spent during its life as a prescription drug can make the difference between a successful switch and a dwindling product, according to Rohinish Hooda, VP of upper respiratory at McNeil Consumer Healthcare